NextCell Pharma AB NXTCL.ST
NXTCL.ST
NextCell Pharma AB PILA.ST
Pila Pharma AB (publ) NICA.ST
Nanologica AB (publ) CMOTEC-B.ST
Scandinavian ChemoTech AB (publ) SPAGO.ST
Spago Nanomedical AB (publ) BIOSGN.ST
Biosergen AB LPGO.ST
Lipigon Pharmaceuticals AB (publ) BIOVIC-B.ST
Biovica International AB (publ) SPRINT.ST
Sprint Bioscience AB (publ) IMMNOV.ST
Immunovia AB (publ)
NextCell Pharma AB PILA.ST
Pila Pharma AB (publ) NICA.ST
Nanologica AB (publ) CMOTEC-B.ST
Scandinavian ChemoTech AB (publ) SPAGO.ST
Spago Nanomedical AB (publ) BIOSGN.ST
Biosergen AB LPGO.ST
Lipigon Pharmaceuticals AB (publ) BIOVIC-B.ST
Biovica International AB (publ) SPRINT.ST
Sprint Bioscience AB (publ) IMMNOV.ST
Immunovia AB (publ)
Performance
| Periode | NXTCL.ST | PILA.ST | NICA.ST | CMOTEC-B.ST | SPAGO.ST | BIOSGN.ST | LPGO.ST | BIOVIC-B.ST | SPRINT.ST | IMMNOV.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -17.05 % | -30.25 % | 23.81 % | 317.69 % | 15.28 % | 59.66 % | 55.29 % | -19.77 % | 6.06 % | 18.61 % |
| YTD | -63.43 % | -44.24 % | -28.57 % | 250.86 % | 20.87 % | -12.45 % | 9.85 % | -71.86 % | -52.70 % | -40.26 % |
| 1Y | -49.51 % | -55.68 % | -47.15 % | 195.19 % | 17.45 % | -33.10 % | -31.96 % | -74.43 % | -65.69 % | -50.00 % |
| 3Y | -89.03 % | -40.67 % | -87.14 % | 3.02 % | -65.42 % | -76.91 % | -90.51 % | -94.06 % | -33.33 % | -99.02 % |
| 5Y | -94.82 % | -75.19 % | -90.11 % | -46.98 % | -95.36 % | -93.31 % | -98.70 % | -98.49 % | -90.75 % | -99.83 % |
| 10Y | -66.82 % | -75.19 % | -92.56 % | -87.11 % | -98.57 % | -93.31 % | -98.70 % | -95.31 % | -98.22 % | -98.82 % |
| From the beginning | -66.82 % | -75.19 % | -92.56 % | -87.11 % | -97.88 % | -93.31 % | -98.70 % | -95.31 % | -95.33 % | -98.82 % |